about
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting ...
Read More
1.19
-0.18
(-13.14%)
4.6M
XNAS Volume
XNAS 13 Mar, 2026 2:48 PM (EDT)
Board Meeting
The next board meeting for Immunic Inc is on 18 Mar 2026 for the purpose of Stifel 2026 Virtual CNS Forum
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Immunic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..